A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone
Giovanna Fattovich(University of Modena and Reggio Emilia), A. Tagger(University of Milan), E. Minola(Humanitas Gavazzeni), Martina Felder(Ospedale di Bolzano), C. Paternoster, Gino Fornaciari(Santa Maria Nuova Hospital), Giulia Tositti(Ospedale San Bortolo), C. Scattolini, M. Pantalena, Caterina Rizzo(University of Pisa), R. Montanari(Ospedale Sacro Cuore Don Calabria), S. Suppressa(Azienda Usl 8 Arezzo), Paolo Fabris(Ospedale San Bortolo), Stefania Boccia(Università Cattolica del Sacro Cuore), E. Castagnetti, P. Rovere(Azienda Ospedaliera Ospedale Civile di Legnano), G. Abbati, A. Tonon(Azienda Ospedaliera Universitaria Integrata Verona), A. Redaelli(Azienda Ospedaliera San Gerardo), I. Zagni, Maria Antonietta Distasi(Ospedaliera di Piacenza), M.L. Ribero(University of Milan), L. Lomonaco, Massimo Giusti(Azienda Usl 8 Arezzo), A. Tomba(Ospedale Sacro Cuore Don Calabria), Franco Noventa(University of Padua)
Cited by 11
Related Papers
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
|Journal of Thrombosis and Haemostasis|2010|1.2k
The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients
|Haematologica|2007|774
Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer
|New England Journal of Medicine|1992|685